NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium.
about
Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.How long has NICE taken to produce Technology Appraisal guidance? A retrospective study to estimate predictors of time to guidance.Health economic decision-making: a comparison between UK and Spain.Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review.What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations?New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes.
P2860
NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@ast
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@en
type
label
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@ast
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@en
prefLabel
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@ast
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@en
P2093
P2860
P1433
P1476
NICE guidance: a comparative s ...... Scottish Medicines Consortium.
@en
P2093
Andrew Walker
Mark Sculpher
Norman Waugh
Pawana Sharma
P2860
P304
P356
10.1136/BMJOPEN-2011-000671
P50
P577
2012-01-30T00:00:00Z